Multinational pharmaceutical company Merck entered into an agreement with the administrative management committee of the Wuxi National High-tech Industrial Development Zone on Thursday. According to the agreement, the industry giant will expand its single-use manufacturing center in Wuxi, East China"s Jiangsu province. Established in September 2018, the center will see its capacity significantly increased thanks to a 100-million-euro ($105.7 million) investment as stated in the agreement. The expansion is aimed at accelerating Merck's Mobius single-use manufacturing and enhancing custom design capabilities in China. Mobius single-use manufacturing includes up-to-date filtration and separation technologies that are widely used in the biopharmaceutical industry.